At 18-month follow-up, no recurrence or progression was observed.<h4>Conclusion</h4>This is the first reported case of a PRRX1::KMT2D fusion mesenchymal neoplasm arising in the mediastinum, which expands the anatomical spectrum of this emerging entity. The gene discussed is PRRX1; the disease is mesenchymal cell neoplasm.